Blood
| [0009]
|
Molecular Therapy
| [0011]
|
Current Protocols in Molecular Biology
| [0015]
|
Molecular Cloning: A Laboratory Manual
| [0015]
|
Oligonucleotide Synthesis
| [0015]
|
Nucleic Acid Hybridization
| [0015]
|
Transcription And Translation
| [0015]
|
Culture Of Animal Cells
| [0015]
|
Immobilized Cells And Enzymes
| [0015]
|
A Practical Guide To Molecular Cloning
| [0015]
|
the series, Methods In ENZYMOLOGY
| [0015]
|
Gene Expression Technology
| [0015]
|
Gene Transfer Vectors For Mammalian Cells
| [0015]
|
Immunochemical Methods In Cell And Molecular Biology
| [0015]
|
Handbook Of Experimental Immunology
| [0015]
|
Manipulating the Mouse Embryo
| [0015]
|
J. of General Virology
| [0037]
|
J. of Gen. Virology
| [0037]
|
Mol. And. Cell. Biology
| [0037]
|
RNA
| [0037]
|
Basic and Clinical Immunology
| [0040]
|
Cell
| [0057]
|
Immun.
| [0057]
|
Citrr. Opin. mm n.
| [0057]
|
Retroviridae: The viruses and their replication
| [0079]
|
Resistance to cytarabine and gemcitabine and in vitro selection of transduced cells after retroviral expression of cytidine deaminase in human hematopoietic progenitor cells.
| [0104]
|
Breaking the code of DNA binding specificity of TAL-type III effectors.
| [0104]
|
Adoptive transfer of allogeneic tumor-specific T cells mediates effective regression of large tumors across major histocompatibility barriers.
| [0104]
|
Generation of EBV-specific cytotoxic T cells that are resistant to calcineurin inhibitors for the treatment of posttransplantation lymphoproliferative disease.
| [0104]
|
Efficient design and assembly of custom TALEN and other TAL effector-based constructs for DNA targeting.
| [0104]
|
Targeting DNA double-strand breaks with TAL effector nucleases.
| [0104]
|
Multiplex genome engineering using CRISPR/Cas systems.
| [0104]
|
DNA end-joining: from yeast to man.
| [0104]
|
CRISPR RNA maturation by trans-encoded small RNA and host factor RNase III.
| [0104]
|
Structural basis for sequence-specific recognition of DNA by TAL effectors.
| [0104]
|
The CRISPR/Cas bacterial immune system cleaves bacteriophage and plasmid DNA.
| [0104]
|
Cas9-crRNA ribonucleoprotein complex mediates specific DNA cleavage for adaptive immunity in bacteria.
| [0104]
|
Transcriptional activators of human genes with programmable DNA-specificity.
| [0104]
|
Genetic modification of mouse bone marrow by lentiviral vector-mediated delivery of hypoxanthine-Guanine phosphoribosyltransferase short hairpin RNA confers chemoprotection against 6-thioguanine cytotoxicity
| [0104]
|
Heritable gene targeting in zebrafish using customized TALENs.
| [0104]
|
Negative regulation of T cell receptor signaling by Siglec-7 (p70/AIRM) and Siglec-9.
| [0104]
|
A programmable dual-RNA-guided DNA endonuclease in adaptive bacterial immunity.
| [0104]
|
Engineering human T cells for resistance to methotrexate and mycophenolate mofetil as an in vivo cell selection strategy.
| [0104]
|
Expression of human glutathione S-transferase P1 confers resistance to benzo[a]pyrene or benzo[a]pyrene-7,8-dihydrodiol mutagenesis, macromolecular alkylation and formation of stable N2-Gua-BPDE adducts in stably transfected V79MZ cells co-expressing hCYP1A1.
| [0104]
|
Complete genome sequence of Burkholderia rhizoxinica, an Endosymbiont of Rhizopus microsporus.
| [0104]
|
Rapid and highly efficient construction of TALE-based transcriptional regulators and nucleases for genome modification.
| [0104]
|
Modularly assembled designer TAL effector nucleases for targeted gene knockout and gene replacement in eukaryotes.
| [0104]
|
Yeast Mre11 and Rad1 proteins define a Ku-independent mechanism to repair double-strand breaks lacking overlapping end sequences.
| [0104]
|
Targeted transcriptional repression using a chimeric TALE-SRDX repressor protein.
| [0104]
|
De novo-engineered transcription activator-like effector (TALE) hybrid nuclease with novel DNA binding specificity creates double-strand breaks.
| [0104]
|
The crystal structure of TAL effector PthXo1 bound to its DNA target.
| [0104]
|
RNA-guided human genome engineering via Cas9.
| [0104]
|
Retroviral-mediated expression of the P140A, but not P140A/G156A, mutant form of O6-methylguanine DNA methyltransferase protects hematopoietic cells against O6-benzylguanine sensitization to chloroethylnitrosourea treatment.
| [0104]
|
LAIR-1, a novel inhibitory receptor expressed on human mononuclear leukocytes.
| [0104]
|
A TALE nuclease architecture for efficient genome editing.
| [0104]
|
Regulation of selected genome loci using de novo-engineered transcription activator-like effector (TALE)-type transcription factors.
| [0104]
|
A simple cipher governs DNA recognition by TAL effectors.
| [0104]
|
A novel TALE nuclease scaffold enables high genome editing activity in combination with low toxicity.
| [0104]
|
Identification and characterization of a novel siglec, siglec-7, expressed by human natural killer cells and monocytes.
| [0104]
|
Engineered resistance to camptothecin and antifolates by retroviral coexpression of tyrosyl DNA phosphodiesterase-I and thymidylate synthase.
| [0104]
|
Treating cancer with genetically engineered T cells.
| [0104]
|
Transcriptional analysis of HIV-specific CD8+ T cells shows that PD-1 inhibits T cell function by upregulating BATF.
| [0104]
|
Co-expression of cytokine and suicide genes to enhance the activity and safety of tumor-specific cytotoxic T lymphocytes.
| [0104]
|
Targeted gene disruption in somatic zebrafish cells using engineered TALENs.
| [0104]
|
Lentiviral vector conferring resistance to mycophenolate mofetil and sensitivity to ganciclovir for in vivo T-cell selection.
| [0104]
|
Dihydrofolate reductase as a therapeutic target.
| [0104]
|
CRISPR-mediated Adaptive Immune Systems in Bacteria and Archaea
| [0104]
|
Homing endonuclease structure and function.
| [0104]
|
Drug-selected co-expression of P-glycoprotein and gp91 in vivo from an MDR1-bicistronic retrovirus vector Ha-MDR-IRES-gp91.
| [0104]
|
Generation of dual resistance to 4-hydroperoxycyclophosphamide and methotrexate by retroviral transfer of the human aldehyde dehydrogenase class 1 gene and a mutated dihydrofolate reductase gene.
| [0104]
|
Knockout rats generated by embryo microinjection of TALENs.
| [0104]
|
Inducible caspase 9 suicide gene to improve the safety of allodepleted T cells after haploidentical stem cell transplantation.
| [0104]
|
Assembly of designer TAL effectors by Golden Gate cloning.
| [0104]
|
Ex vivo selection and expansion of cells based on expression of a mutated inosine monophosphate dehydrogenase 2 after HIV vector transduction: effects on lymphocytes, monocytes, and CD34+ stem cells.
| [0104]
|
Efficient construction of sequence-specific TAL effectors for modulating mammalian transcription.
| [0104]
|
Siglec-9, a novel sialic acid binding member of the immunoglobulin superfamily expressed broadly on human blood leukocytes.
| [0104]
|
In vivo selection of MGMT(P140K) lentivirus-transduced human NOD/SCID repopulating cells without pretransplant irradiation conditioning.
| [0104]
|